Relationship between cigarette use and prostate cancer risk: what do we know and what should we do?

José Ignacio Nolazco^{1

2}, Lorelei A Mucci³, Roman Sosnowski⁴, Krzysztof Przewoźniak^{5

6}, Steven L Chang^{7

8}, Cosimo De Nunzio⁹

Affiliations

¹ Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. jnolazco@bwh.harvard.edu.
² Servicio de Urología, Hospital Universitario Austral, Universidad Austral, Pilar, Argentina. jnolazco@bwh.harvard.edu.
³ Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
⁴ Department of Urogenital Cancer, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
⁵ Department of Cancer Epidemiology and Primary Prevention, Maria Skłodowska Curie National Research Institute of Oncology, Warsaw, Poland.
⁶ Global Institute of Family Health, Calisia University, Calisia, Poland.
⁷ Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
⁸ Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
⁹ Department of Urology, Sant'Andrea Hospital, Sapienza University, Rome, Italy.

Review

José Ignacio Nolazco et al. Prostate Cancer Prostatic Dis. 2023 Sep.

. 2023 Sep;26(3):516-518.

doi: 10.1038/s41391-023-00671-5. Epub 2023 Apr 22.

José Ignacio Nolazco^{1

2}, Lorelei A Mucci³, Roman Sosnowski⁴, Krzysztof Przewoźniak^{5

6}, Steven L Chang^{7

8}, Cosimo De Nunzio⁹

¹ Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. jnolazco@bwh.harvard.edu.
² Servicio de Urología, Hospital Universitario Austral, Universidad Austral, Pilar, Argentina. jnolazco@bwh.harvard.edu.
³ Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
⁴ Department of Urogenital Cancer, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
⁵ Department of Cancer Epidemiology and Primary Prevention, Maria Skłodowska Curie National Research Institute of Oncology, Warsaw, Poland.
⁶ Global Institute of Family Health, Calisia University, Calisia, Poland.
⁷ Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
⁸ Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
⁹ Department of Urology, Sant'Andrea Hospital, Sapienza University, Rome, Italy.

No abstract available

References

1. Wang L, Lu B, He M, Wang Y, Wang Z, Du L. Prostate cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019. Front Public Health. 2022;10:811044. - PubMed - PMC - DOI
1. Safiri S, Nejadghaderi SA, Abdollahi M, Carson-Chahhoud K, Kaufman JS, Bragazzi NL, et al. Global, regional, and national burden of cancers attributable to tobacco smoking in 204 countries and territories, 1990-2019. Cancer Med. 2022;11:2662–78. - PubMed - PMC - DOI
1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum. 2004;83:1–1438. - PMC
1. Huncharek M, Haddock KS, Reid R, Kupelnick B. Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies. Am J Public Health. 2010;100:693–701. - PubMed - PMC - DOI
1. De Nunzio C, Tema G, Lombardo R, Trucchi A, Bellangino M, Esperto F, et al. Cigarette smoking is not associated with prostate cancer diagnosis and aggressiveness: a cross sectional Italian study. Minerva Urol Nefrol. 2018;70:598–605. - PubMed - DOI